Limitations of analyses based on achieved blood pressure

Lessons from the African American Study of Kidney Disease and Hypertension Trial

Esa M. Davis, Lawrence J. Appel, Xuelei Wang, Tom Greene, Brad C. Astor, Mahboob Rahman, Robert Toto, Michael S. Lipkowitz, Velvie A. Pogue, Jackson T. Wright

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Blood pressure (BP) guidelines that set target BP levels often rely on analyses of achieved BP from hypertension treatment trials. The objective of this article was to compare the results of analyses of achieved BP to intention-to-treat analyses on renal disease progression. Participants (n=1094) in the African-American Study of Kidney Disease and Hypertension Trial were randomly assigned to either usual BP goal defined by a mean arterial pressure goal of 102 to 107 mm Hg or lower BP goal defined by a mean arterial pressure goal of ≤92 mm Hg. Median follow-up was 3.7 years. Primary outcomes were rate of decline in measured glomerular filtration rate and a composite of a decrease in glomerular filtration rate by >50% or >25 mL/min per 1.73 m 2, requirement for dialysis, transplantation, or death. Intention-to-treat analyses showed no evidence of a BP effect on either the rate of decline in glomerular filtration rate or the clinical composite outcome. In contrast, the achieved BP analyses showed that each 10-mm Hg increment in mean follow-up achieved mean arterial pressure was associated with a 0.35 mL/min per 1.73 m2 (95% CI: 0.08 to 0.62 mL/min per 1.73 m; P=0.01) faster mean glomerular filtration rate decline and a 17% (95% CI: 5% to 32%; P=0.006) increased risk of the clinical composite outcome. Analyses based on achieved BP lead to markedly different inferences than traditional intention-to-treat analyses, attributed in part to confounding of achieved BP with comorbidities, disease severity, and adherence. Clinicians and policy makers should exercise caution when making treatment recommendations based on analyses relating outcomes to achieved BP.

Original languageEnglish (US)
Pages (from-to)1061-1068
Number of pages8
JournalHypertension
Volume57
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Kidney Diseases
African Americans
Blood Pressure
Hypertension
Glomerular Filtration Rate
Intention to Treat Analysis
Arterial Pressure
Administrative Personnel
Disease Progression
Comorbidity
Dialysis
Transplantation
Guidelines
Exercise
Kidney

Keywords

  • blacks
  • blood pressure control
  • hypertension treatment
  • renal disease

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Limitations of analyses based on achieved blood pressure : Lessons from the African American Study of Kidney Disease and Hypertension Trial. / Davis, Esa M.; Appel, Lawrence J.; Wang, Xuelei; Greene, Tom; Astor, Brad C.; Rahman, Mahboob; Toto, Robert; Lipkowitz, Michael S.; Pogue, Velvie A.; Wright, Jackson T.

In: Hypertension, Vol. 57, No. 6, 06.2011, p. 1061-1068.

Research output: Contribution to journalArticle

Davis, EM, Appel, LJ, Wang, X, Greene, T, Astor, BC, Rahman, M, Toto, R, Lipkowitz, MS, Pogue, VA & Wright, JT 2011, 'Limitations of analyses based on achieved blood pressure: Lessons from the African American Study of Kidney Disease and Hypertension Trial', Hypertension, vol. 57, no. 6, pp. 1061-1068. https://doi.org/10.1161/HYPERTENSIONAHA.111.169367
Davis, Esa M. ; Appel, Lawrence J. ; Wang, Xuelei ; Greene, Tom ; Astor, Brad C. ; Rahman, Mahboob ; Toto, Robert ; Lipkowitz, Michael S. ; Pogue, Velvie A. ; Wright, Jackson T. / Limitations of analyses based on achieved blood pressure : Lessons from the African American Study of Kidney Disease and Hypertension Trial. In: Hypertension. 2011 ; Vol. 57, No. 6. pp. 1061-1068.
@article{5712c82f3b3b4223bc114a0d12e2e265,
title = "Limitations of analyses based on achieved blood pressure: Lessons from the African American Study of Kidney Disease and Hypertension Trial",
abstract = "Blood pressure (BP) guidelines that set target BP levels often rely on analyses of achieved BP from hypertension treatment trials. The objective of this article was to compare the results of analyses of achieved BP to intention-to-treat analyses on renal disease progression. Participants (n=1094) in the African-American Study of Kidney Disease and Hypertension Trial were randomly assigned to either usual BP goal defined by a mean arterial pressure goal of 102 to 107 mm Hg or lower BP goal defined by a mean arterial pressure goal of ≤92 mm Hg. Median follow-up was 3.7 years. Primary outcomes were rate of decline in measured glomerular filtration rate and a composite of a decrease in glomerular filtration rate by >50{\%} or >25 mL/min per 1.73 m 2, requirement for dialysis, transplantation, or death. Intention-to-treat analyses showed no evidence of a BP effect on either the rate of decline in glomerular filtration rate or the clinical composite outcome. In contrast, the achieved BP analyses showed that each 10-mm Hg increment in mean follow-up achieved mean arterial pressure was associated with a 0.35 mL/min per 1.73 m2 (95{\%} CI: 0.08 to 0.62 mL/min per 1.73 m; P=0.01) faster mean glomerular filtration rate decline and a 17{\%} (95{\%} CI: 5{\%} to 32{\%}; P=0.006) increased risk of the clinical composite outcome. Analyses based on achieved BP lead to markedly different inferences than traditional intention-to-treat analyses, attributed in part to confounding of achieved BP with comorbidities, disease severity, and adherence. Clinicians and policy makers should exercise caution when making treatment recommendations based on analyses relating outcomes to achieved BP.",
keywords = "blacks, blood pressure control, hypertension treatment, renal disease",
author = "Davis, {Esa M.} and Appel, {Lawrence J.} and Xuelei Wang and Tom Greene and Astor, {Brad C.} and Mahboob Rahman and Robert Toto and Lipkowitz, {Michael S.} and Pogue, {Velvie A.} and Wright, {Jackson T.}",
year = "2011",
month = "6",
doi = "10.1161/HYPERTENSIONAHA.111.169367",
language = "English (US)",
volume = "57",
pages = "1061--1068",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Limitations of analyses based on achieved blood pressure

T2 - Lessons from the African American Study of Kidney Disease and Hypertension Trial

AU - Davis, Esa M.

AU - Appel, Lawrence J.

AU - Wang, Xuelei

AU - Greene, Tom

AU - Astor, Brad C.

AU - Rahman, Mahboob

AU - Toto, Robert

AU - Lipkowitz, Michael S.

AU - Pogue, Velvie A.

AU - Wright, Jackson T.

PY - 2011/6

Y1 - 2011/6

N2 - Blood pressure (BP) guidelines that set target BP levels often rely on analyses of achieved BP from hypertension treatment trials. The objective of this article was to compare the results of analyses of achieved BP to intention-to-treat analyses on renal disease progression. Participants (n=1094) in the African-American Study of Kidney Disease and Hypertension Trial were randomly assigned to either usual BP goal defined by a mean arterial pressure goal of 102 to 107 mm Hg or lower BP goal defined by a mean arterial pressure goal of ≤92 mm Hg. Median follow-up was 3.7 years. Primary outcomes were rate of decline in measured glomerular filtration rate and a composite of a decrease in glomerular filtration rate by >50% or >25 mL/min per 1.73 m 2, requirement for dialysis, transplantation, or death. Intention-to-treat analyses showed no evidence of a BP effect on either the rate of decline in glomerular filtration rate or the clinical composite outcome. In contrast, the achieved BP analyses showed that each 10-mm Hg increment in mean follow-up achieved mean arterial pressure was associated with a 0.35 mL/min per 1.73 m2 (95% CI: 0.08 to 0.62 mL/min per 1.73 m; P=0.01) faster mean glomerular filtration rate decline and a 17% (95% CI: 5% to 32%; P=0.006) increased risk of the clinical composite outcome. Analyses based on achieved BP lead to markedly different inferences than traditional intention-to-treat analyses, attributed in part to confounding of achieved BP with comorbidities, disease severity, and adherence. Clinicians and policy makers should exercise caution when making treatment recommendations based on analyses relating outcomes to achieved BP.

AB - Blood pressure (BP) guidelines that set target BP levels often rely on analyses of achieved BP from hypertension treatment trials. The objective of this article was to compare the results of analyses of achieved BP to intention-to-treat analyses on renal disease progression. Participants (n=1094) in the African-American Study of Kidney Disease and Hypertension Trial were randomly assigned to either usual BP goal defined by a mean arterial pressure goal of 102 to 107 mm Hg or lower BP goal defined by a mean arterial pressure goal of ≤92 mm Hg. Median follow-up was 3.7 years. Primary outcomes were rate of decline in measured glomerular filtration rate and a composite of a decrease in glomerular filtration rate by >50% or >25 mL/min per 1.73 m 2, requirement for dialysis, transplantation, or death. Intention-to-treat analyses showed no evidence of a BP effect on either the rate of decline in glomerular filtration rate or the clinical composite outcome. In contrast, the achieved BP analyses showed that each 10-mm Hg increment in mean follow-up achieved mean arterial pressure was associated with a 0.35 mL/min per 1.73 m2 (95% CI: 0.08 to 0.62 mL/min per 1.73 m; P=0.01) faster mean glomerular filtration rate decline and a 17% (95% CI: 5% to 32%; P=0.006) increased risk of the clinical composite outcome. Analyses based on achieved BP lead to markedly different inferences than traditional intention-to-treat analyses, attributed in part to confounding of achieved BP with comorbidities, disease severity, and adherence. Clinicians and policy makers should exercise caution when making treatment recommendations based on analyses relating outcomes to achieved BP.

KW - blacks

KW - blood pressure control

KW - hypertension treatment

KW - renal disease

UR - http://www.scopus.com/inward/record.url?scp=79956341653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956341653&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.111.169367

DO - 10.1161/HYPERTENSIONAHA.111.169367

M3 - Article

VL - 57

SP - 1061

EP - 1068

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 6

ER -